Peroxisome Proliferator-Activated Receptors as a Therapeutic Target in Asthma
The complexity of the pathogenetic mechanisms of the development of chronic inflammation in asthma determines its heterogeneity and insufficient treatment effectiveness. Nuclear transcription factors, which include peroxisome proliferator-activated receptors, that is, PPARs, play an important role i...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | PPAR Research |
| Online Access: | http://dx.doi.org/10.1155/2020/8906968 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849307284329463808 |
|---|---|
| author | Oxana Yu. Kytikova Juliy M. Perelman Tatyana P. Novgorodtseva Yulia K. Denisenko Viktor P. Kolosov Marina V. Antonyuk Tatyana A. Gvozdenko |
| author_facet | Oxana Yu. Kytikova Juliy M. Perelman Tatyana P. Novgorodtseva Yulia K. Denisenko Viktor P. Kolosov Marina V. Antonyuk Tatyana A. Gvozdenko |
| author_sort | Oxana Yu. Kytikova |
| collection | DOAJ |
| description | The complexity of the pathogenetic mechanisms of the development of chronic inflammation in asthma determines its heterogeneity and insufficient treatment effectiveness. Nuclear transcription factors, which include peroxisome proliferator-activated receptors, that is, PPARs, play an important role in the regulation of initiation and resolution of the inflammatory process. The ability of PPARs to modulate not only lipid homeostasis but also the activity of the inflammatory response makes them an important pathogenetic target in asthma therapy. At present, special attention is focused on natural (polyunsaturated fatty acids (PUFAs), endocannabinoids, and eicosanoids) and synthetic (fibrates, thiazolidinediones) PPAR ligands and the study of signaling mechanisms involved in the implementation of their anti-inflammatory effects in asthma. This review summarizes current views on the structure and function of PPARs, as well as their participation in the pathogenesis of chronic inflammation in asthma. The potential use of PPAR ligands as therapeutic agents for treating asthma is under discussion. |
| format | Article |
| id | doaj-art-22b043aa86794485bc0f70ce593c46b0 |
| institution | Kabale University |
| issn | 1687-4757 1687-4765 |
| language | English |
| publishDate | 2020-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | PPAR Research |
| spelling | doaj-art-22b043aa86794485bc0f70ce593c46b02025-08-20T03:54:48ZengWileyPPAR Research1687-47571687-47652020-01-01202010.1155/2020/89069688906968Peroxisome Proliferator-Activated Receptors as a Therapeutic Target in AsthmaOxana Yu. Kytikova0Juliy M. Perelman1Tatyana P. Novgorodtseva2Yulia K. Denisenko3Viktor P. Kolosov4Marina V. Antonyuk5Tatyana A. Gvozdenko6Vladivostok Branch of Far Eastern Scientific Centre of Physiology and Pathology of Respiration, Institute of Medical Climatology and Rehabilitative Treatment, Vladivostok, RussiaFar Eastern Scientific Center of Physiology and Pathology of Respiration, Russian Academy of Sciences, Blagoveshchensk, RussiaVladivostok Branch of Far Eastern Scientific Centre of Physiology and Pathology of Respiration, Institute of Medical Climatology and Rehabilitative Treatment, Vladivostok, RussiaVladivostok Branch of Far Eastern Scientific Centre of Physiology and Pathology of Respiration, Institute of Medical Climatology and Rehabilitative Treatment, Vladivostok, RussiaFar Eastern Scientific Center of Physiology and Pathology of Respiration, Russian Academy of Sciences, Blagoveshchensk, RussiaVladivostok Branch of Far Eastern Scientific Centre of Physiology and Pathology of Respiration, Institute of Medical Climatology and Rehabilitative Treatment, Vladivostok, RussiaVladivostok Branch of Far Eastern Scientific Centre of Physiology and Pathology of Respiration, Institute of Medical Climatology and Rehabilitative Treatment, Vladivostok, RussiaThe complexity of the pathogenetic mechanisms of the development of chronic inflammation in asthma determines its heterogeneity and insufficient treatment effectiveness. Nuclear transcription factors, which include peroxisome proliferator-activated receptors, that is, PPARs, play an important role in the regulation of initiation and resolution of the inflammatory process. The ability of PPARs to modulate not only lipid homeostasis but also the activity of the inflammatory response makes them an important pathogenetic target in asthma therapy. At present, special attention is focused on natural (polyunsaturated fatty acids (PUFAs), endocannabinoids, and eicosanoids) and synthetic (fibrates, thiazolidinediones) PPAR ligands and the study of signaling mechanisms involved in the implementation of their anti-inflammatory effects in asthma. This review summarizes current views on the structure and function of PPARs, as well as their participation in the pathogenesis of chronic inflammation in asthma. The potential use of PPAR ligands as therapeutic agents for treating asthma is under discussion.http://dx.doi.org/10.1155/2020/8906968 |
| spellingShingle | Oxana Yu. Kytikova Juliy M. Perelman Tatyana P. Novgorodtseva Yulia K. Denisenko Viktor P. Kolosov Marina V. Antonyuk Tatyana A. Gvozdenko Peroxisome Proliferator-Activated Receptors as a Therapeutic Target in Asthma PPAR Research |
| title | Peroxisome Proliferator-Activated Receptors as a Therapeutic Target in Asthma |
| title_full | Peroxisome Proliferator-Activated Receptors as a Therapeutic Target in Asthma |
| title_fullStr | Peroxisome Proliferator-Activated Receptors as a Therapeutic Target in Asthma |
| title_full_unstemmed | Peroxisome Proliferator-Activated Receptors as a Therapeutic Target in Asthma |
| title_short | Peroxisome Proliferator-Activated Receptors as a Therapeutic Target in Asthma |
| title_sort | peroxisome proliferator activated receptors as a therapeutic target in asthma |
| url | http://dx.doi.org/10.1155/2020/8906968 |
| work_keys_str_mv | AT oxanayukytikova peroxisomeproliferatoractivatedreceptorsasatherapeutictargetinasthma AT juliymperelman peroxisomeproliferatoractivatedreceptorsasatherapeutictargetinasthma AT tatyanapnovgorodtseva peroxisomeproliferatoractivatedreceptorsasatherapeutictargetinasthma AT yuliakdenisenko peroxisomeproliferatoractivatedreceptorsasatherapeutictargetinasthma AT viktorpkolosov peroxisomeproliferatoractivatedreceptorsasatherapeutictargetinasthma AT marinavantonyuk peroxisomeproliferatoractivatedreceptorsasatherapeutictargetinasthma AT tatyanaagvozdenko peroxisomeproliferatoractivatedreceptorsasatherapeutictargetinasthma |